Related Experiment Videos
A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth
Valeria R Fantin1, Marcelo J Berardi, Luca Scorrano
1Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Abstract:
Tumorigenesis results from events that impinge on a variety of collaborating metabolic pathways. To assess their role in this process, we utilized a cell-based assay to perform a high-throughput, chemical library screen. In so doing, we identified F16, a small molecule that selectively inhibits proliferation of mammary epithelial, neu-overexpressing cells, as well as a variety of mouse mammary tumor and human breast cancer cell lines. F16 belongs to a group of structurally similar molecules with a delocalized positive charge. The compound is accumulated in mitochondria of responsive cells, driven by the membrane potential, and it compromises their functional integrity. Mitochondrial hyperpolarization is a shared feature of many tumor cell lines, explaining the broad action spectrum of this novel delocalized lipophilic cation.
Insights
Researchers discovered F16, a novel small molecule that inhibits the proliferation of various cancer cells. This compound targets mitochondria, exploiting a common tumor cell characteristic called mitochondrial hyperpolarization for its broad anti-cancer effects.
Area of Science:
- Molecular Biology
- Cancer Research
- Biochemistry
Background:
- Tumorigenesis involves complex interactions within metabolic pathways.
- Understanding these pathways is crucial for developing targeted cancer therapies.
- Mammary epithelial cells and specific tumor types exhibit unique metabolic characteristics.
Purpose of the Study:
- To identify small molecules that inhibit tumor cell proliferation.
- To investigate the role of metabolic pathways in tumorigenesis.
- To characterize the mechanism of action for novel anti-cancer compounds.
Main Methods:
- High-throughput chemical library screening using a cell-based assay.
- Selective inhibition assays on mammary epithelial and various cancer cell lines.
- Mitochondrial localization studies and functional integrity assessments.
Main Results:
- Identified F16, a small molecule inhibiting proliferation of neu-overexpressing mammary epithelial cells, mouse mammary tumors, and human breast cancer lines.
- F16, a delocalized lipophilic cation, accumulates in mitochondria of responsive cells.
- F16 compromises mitochondrial functional integrity, linked to mitochondrial hyperpolarization common in tumor cells.
Conclusions:
- F16 demonstrates selective anti-proliferative activity against a range of cancer cell types.
- The compound's mechanism involves targeting mitochondrial function via membrane potential-driven accumulation.
- Mitochondrial hyperpolarization is a key vulnerability exploited by F16, suggesting broad therapeutic potential.